問卷

TPIDB > 臨床試驗主持人

臨床試驗主持人



更新時間:2025-03-10

邱瀚模CHIU, HAN-MO
  • 協同主持人
  • 執行臨床試驗年資 12 年 9 個月

發表文獻

56

1

Chang LC, Chiu HM, Ho BC, Chen MH, Hsu YC, Chiu WT, Su KY, Shun CT, Liang JT, Yu SL, Wu MS. Copy Number Alterations of Depressed Colorectal Neoplasm Predict the Survival and Response to Oxaliplatin in Proximal Colon Cancer. Cancers (Basel). 2020 Jun 10;12(6):1527. doi: 10.3390/cancers12061527. PMID: 32532105; PMCID: PMC7352996.

2

Chang LC, Chiu HM, Wu MS, Shen TL. The Role of Small Extracellular Vesicles in the Progression of Colorectal Cancer and Its Clinical Applications. Int J Mol Sci. 2022 Jan 26;23(3):1379. doi: 10.3390/ijms23031379. PMID: 35163305; PMCID: PMC8835972.

3

Chang LC, Hsu YC, Chiu HM, Ueda K, Wu MS, Kao CH, Shen TL. Exploration of the Proteomic Landscape of Small Extracellular Vesicles in Serum as Biomarkers for Early Detection of Colorectal Neoplasia. Front Oncol. 2021 Sep 13;11:732743. doi: 10.3389/fonc.2021.732743. PMID: 34589434; PMCID: PMC8473825.

4

Chang LC, Shun CT, Lin BR, Sanduleanu S, Hsu WF, Wu MS, Chiu HM. Recurrence Outcomes Less Favorable in T1 Rectal Cancer than in T1 Colon Cancer. Oncologist. 2021 Sep;26(9):e1548-e1554. doi: 10.1002/onco.13815. Epub 2021 May 26. PMID: 33955121; PMCID: PMC8417849.

5

Chang WY, Chiu HM. Beyond colonoscopy: Physical activity as a viable adjunct to prevent colorectal cancer. Dig Endosc. 2023 Jan;35(1):33-46. doi: 10.1111/den.14377. Epub 2022 Aug 17. PMID: 35694899.

6

Chang WY, Chiu HM. Bringing fecal immunochemical test into play in symptomatic population: Exploring the feasibility of fecal immunochemical test-symptom combined approach. J Gastroenterol Hepatol. 2020 Jun;35(6):911-912. doi: 10.1111/jgh.15100. PMID: 32537752.

7

Chang WY, Chiu HM. Can image-enhanced endoscopy improve adenoma detection rate? Dig Endosc. 2022 Jan;34(2):284-296. doi: 10.1111/den.14102. Epub 2021 Aug 27. PMID: 34351014.

8

Chang WY, Chiu HM. Synergistic or independent? Revisiting colonoscopic surveillance for conventional and serrated lesions. Dig Endosc. 2022 May;34(4):858-861. doi: 10.1111/den.14227. Epub 2022 Jan 20. PMID: 35048427.

9

Chang WY, Lin HH, Chang LC, Hsu WF, Wu MS, Chiu HM. Active exercise after polypectomy reduces the risk of metachronous advanced colorectal neoplasm. Dig Endosc. 2022 May;34(4):828-837. doi: 10.1111/den.14127. Epub 2021 Sep 24. PMID: 34516690.

10

Cheng SY, Chen CF, He HC, Chang LC, Hsu WF, Wu MS, Chiu HM. Impact of COVID-19 pandemic on fecal immunochemical test screening uptake and compliance to diagnostic colonoscopy. J Gastroenterol Hepatol. 2021 Jun;36(6):1614-1619. doi: 10.1111/jgh.15325. Epub 2020 Dec 2. PMID: 33217055; PMCID: PMC7753615.